Evoke Pharma Inc.

NASDAQ: EVOK · Real-Time Price · USD
5.05
-0.09 (-1.75%)
At close: Aug 15, 2025, 12:49 PM

Evoke Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
10.25M 5.18M 2.51M 1.62M
Cost of Revenue
356.53K 201.88K 370.39K 328.12K
Gross Profit
9.89M 4.98M 2.14M 1.29M
Operating Income
-5.2M -7.43M -7.79M -8.15M
Interest Income
353.31K 138.6K 62.01K 8.62K
Pretax Income
-5.35M -7.79M -8.22M -8.54M
Net Income
-5.35M -7.79M -8.16M -9.03M
Selling & General & Admin
15.08M 12.23M 9.62M 8.85M
Research & Development
16.32K 181.91K 300.79K 590.48K
Other Expenses
n/a n/a n/a n/a
Operating Expenses
15.1M 12.41M 9.92M 9.44M
Interest Expense
501.37K 500K 500K 500.05K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
15.45M 12.61M 10.29M 9.77M
Income Tax Expense
n/a n/a -62.01K 491.44K
Shares Outstanding (Basic)
1.91M 278.56K 261.97K 223.51K
Shares Outstanding (Diluted)
1.91M 278.56K 261.97K 223.51K
EPS (Basic)
-2.81 -27.97 -31.16 -40.4
EPS (Diluted)
-2.81 -27.97 -31.16 -40.4
EBITDA
-4.85M -7.29M -7.72M -8.04M
EBIT
-4.85M -7.29M -7.72M -8.04M
Depreciation & Amortization
n/a 138.6K 7.79M 8.15M